跳至主要内容
临床试验/IRCT20170202032367N4
IRCT20170202032367N4已完成3 期

The effect of L-Arginine supplementation on the levels of glucose, N-Terminal pro Brain Natriuretic Peptide (NT pro-BNP), lipids, blood pressure, ejection fraction, quality of life and rehabilitation in patients with congestive heart failure.

Tehran University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
35 years 至 65 years(—)
性别
All

入选标准

  • Age 35-60 years
  • Diagnosis of ischemic heart failure
  • Ejection fraction less than 40% (based on echocardiography test)
  • Cardiac functional level of 2 or 3 based on the classification of the New York heart association

排除标准

  • Kidney, liver or inflammatory bowel diseases, malignancies, thyroid disorders
  • Pregnancy and lactation
  • Taking any dietary supplement including L-arginine within the past 2 months prior to the initiation of the study
  • History of angina pectoris, myocardial infarction or stroke, untreated arrhythmias
  • Taking medications including glucocorticoids, antiarrhythmic or chemotherapy agents, NSAIDs, diltiazem, verapamil, thiazolidinedione
  • Unable to perform 6 minute walking test

研究者

相似试验